Related Experiment Video
Updated: Jul 15, 2026

08:52
Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
Published on: July 26, 2019
Influenza vaccination in Austria, 1982-2003
Ursula Kunze1, Ernest Groman, Gabriela Böhm
1Institute of Social Medicine, Center of Public Health, Medical University of Vienna, Rooseveltplatz 3, 1090 Vienna, Austria. ursula.kunze@meduniwien.ac.at
Wiener Medizinische Wochenschrift (1946)
|April 12, 2007
Summary
Influenza vaccination rates in developed countries increased from 1980-2003, but Austria remained a low-use country. Reasons include misidentification of illness, lack of insurance coverage, and inconsistent medical recommendations.
Area of Science:
- Public Health
- Epidemiology
- Vaccinology
Background:
- Influenza vaccination is a key public health strategy.
- Global influenza vaccine uptake has been monitored since the early 1990s.
- Comparative studies assess vaccine distribution across developed nations.
Purpose of the Study:
- To analyze trends in influenza vaccine utilization in developed countries.
- To identify factors contributing to low influenza vaccination rates in Austria.
- To emphasize the need for increased public awareness regarding influenza vaccination.
Main Methods:
- Collected annual influenza vaccine distribution data per 1000 population.
- Compared vaccination rates across 18-22 developed countries from 1980 to 2003.
- Analyzed potential reasons for low vaccine uptake in specific countries, particularly Austria.
Main Results:
- Influenza vaccine use generally increased from 1980 to 2003 in most studied countries.
- Austria exhibited consistently low vaccination rates, despite recommendations for high-risk groups.
- Austria's rates (e.g., 52 doses/1000 in 1995, 127 doses/1000 in 2003) lagged behind countries like Spain (160 doses/1000 in 1995).
Conclusions:
- Despite overall increases, influenza vaccination remains underutilized in some developed nations like Austria.
- Barriers to vaccination in Austria include public confusion, lack of insurance reimbursement, and medical community discordance.
- Enhanced public awareness and policy changes are crucial, especially in light of potential influenza pandemics.
Related Concept Videos
Influenza
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Vaccinations
Overview
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Smallpox
Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.

